Introduction

Tagrisso tablet, with its active ingredient osimertinib, is a medication primarily prescribed for the treatment of certain types of lung cancer. It belongs to a class of drugs known as kinase inhibitors, which work by blocking the action of abnormal proteins that promote the growth of cancer cells. Understanding its uses and precautions is crucial for patients and healthcare providers alike.

Tagrisso tablet

Uses

1. Treatment of Non-Small Cell Lung Cancer (NSCLC)

Tagrisso is primarily used for the treatment of metastatic non-small cell lung cancer (NSCLC) that harbors specific mutations in the epidermal growth factor receptor (EGFR) gene. These mutations, such as exon 19 deletions or exon 21 L858R mutations, make cancer cells more sensitive to drugs like Tagrisso.

2. First-Line Therapy

Tagrisso is often prescribed as a first-line treatment for NSCLC patients with EGFR mutations, particularly those with advanced or metastatic disease. It has shown significant efficacy in delaying disease progression and improving overall survival rates compared to traditional chemotherapy options.

3. Adjuvant Therapy

In some cases, Tagrisso may be used as adjuvant therapy following surgical resection of early-stage NSCLC with EGFR mutations. Adjuvant therapy aims to reduce the risk of cancer recurrence and improve long-term outcomes.

Precautions

1. EGFR Mutation Testing

Before initiating treatment with Tagrisso 80 mg tablet cost, it is essential for healthcare providers to confirm the presence of EGFR mutations in the patient’s tumor tissue. This testing helps identify patients who are most likely to benefit from Tagrisso therapy.

2. Drug Interactions

Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking, as some drugs may interact with Tagrisso, potentially affecting its efficacy or increasing the risk of adverse reactions.

3. Side Effects

Like any medication, Tagrisso can cause side effects, which may vary from person to person. Common side effects include diarrhea, skin rash, nausea, fatigue, decreased appetite, and respiratory issues. Patients should report any unusual or severe side effects to their healthcare provider promptly.

4. Pregnancy and Breastfeeding

Tagrisso may cause harm to a developing fetus, and it is not recommended for use during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a certain period afterward. It is also not known whether Tagrisso passes into breast milk, so breastfeeding is not recommended while taking Tagrisso.

5. Liver and Kidney Function

Patients with pre-existing liver or kidney conditions may require dose adjustments or closer monitoring while taking Tagrisso. Healthcare providers should assess liver and kidney function before initiating treatment and periodically during therapy.

6. Lung Disease

Patients with pre-existing interstitial lung disease (ILD) or pneumonitis may be at increased risk of exacerbation while taking Tagrisso. Close monitoring for respiratory symptoms is recommended, and treatment may need to be discontinued if ILD or pneumonitis develop.

Side Effects

Tagrisso tablet, containing the active ingredient osimertinib, is a medication used primarily in the treatment of non-small cell lung cancer (NSCLC). While Tagrisso is effective in targeting cancer cells with specific mutations, it can also produce side effects in some individuals. Here are some common side effects associated with Tagrisso:

1. Diarrhea

Diarrhea is one of the most frequently reported side effects of Tagrisso. It can range from mild to severe and may require medical intervention or adjustments to the treatment regimen.

2. Skin Rash

Some patients may develop a skin rash while taking Tagrisso. This rash can vary in severity and may cause itching, redness, or irritation. In some cases, the rash may require treatment with topical or oral medications.

3. Nausea and Vomiting

Nausea and vomiting are common side effects of many cancer medications, including Tagrisso. Patients experiencing persistent or severe nausea and vomiting should inform their healthcare provider for appropriate management.

4. Fatigue

Fatigue, or tiredness, is another common side effect reported by patients taking Tagrisso. It can significantly impact daily activities and the quality of life. Patients should rest as needed and consult their healthcare provider if fatigue becomes debilitating.

5. Decreased Appetite

Some individuals may experience a loss of appetite while taking Tagrisso. Maintaining proper nutrition is essential during cancer treatment, so patients should discuss any significant changes in appetite with their healthcare provider.

6. Respiratory Issues

Tagrisso can sometimes cause respiratory problems such as coughing, shortness of breath, or difficulty breathing. Patients experiencing any respiratory symptoms should seek medical attention promptly.

7. Electrolyte Imbalance

How much is Tagrisso tablets may affect the levels of electrolytes such as potassium, sodium, and calcium in the body. Healthcare providers may monitor electrolyte levels through blood tests and recommend appropriate interventions if imbalances occur.

8. Cardiac Effects

In some cases, Tagrisso may lead to cardiac issues such as heart palpitations or changes in heart rhythm. Patients with pre-existing heart conditions should be closely monitored while taking Tagrisso.

9. Liver and Kidney Problems

Tagrisso can impact liver and kidney function in some individuals, leading to elevated liver enzymes or changes in kidney function tests. Regular monitoring of liver and kidney function is essential during treatment with Tagrisso.

Prices

You can get 30 Tagrisso tablet for 490,000 PKR from here.

Conclusion

Tagrisso tablets are a valuable treatment option for patients with EGFR-mutated non-small cell lung cancer, offering improved outcomes and survival rates. However, it is essential to use this medication cautiously and under the guidance of a qualified healthcare professional to maximize its benefits and minimize the risk of adverse effects. If you need any consulting regarding medicines, you can contact Health To Wealth.

FAQs

1. What is Tagrisso, and what is it used for?

Tagrisso tablet is a medication containing the active ingredient osimertinib. It is primarily used for the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene.

2. How does Tagrisso work?

Cost of Tagrisso 80mg tablets daily is a type of kinase inhibitor that works by blocking the action of abnormal proteins produced by EGFR-mutated cancer cells. This helps to slow down or stop the growth and spread of cancer cells.

3. Who is eligible for treatment with Tagrisso?

Patients diagnosed with metastatic NSCLC who have been tested positive for EGFR mutations, such as exon 19 deletions or exon 21 L858R mutations, are eligible for treatment with Tagrisso.

4. Is Tagrisso a first-line treatment for NSCLC?

Yes, Tagrisso is often prescribed as a first-line treatment for NSCLC patients with EGFR mutations, particularly those with advanced or metastatic disease.

5. What are the common side effects of Tagrisso tablet?

Common side effects of Tagrisso include diarrhea, skin rash, nausea, fatigue, decreased appetite, respiratory issues, electrolyte imbalance, and cardiac effects. Patients should discuss any side effects with their healthcare provider.

6. Can Tagrisso tablet be taken during pregnancy or breastfeeding?

Tagrisso tablet may cause harm to a developing fetus, and it is not recommended for use during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a certain period afterward. It is also not known whether Tagrisso passes into breast milk, so breastfeeding is not recommended while taking Tagrisso.

7. Are there any drug interactions with Tagrisso tablet?

Yes, Tagrisso tablet may interact with certain medications, supplements, or herbal products. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Disclaimer

The information provided on this blog regarding medicines, their uses, precautions, side effects, and prices is solely based on data collected from public domains. We are not doctors or medical professionals. While we strive to provide accurate and up-to-date information to our viewers, we can’t guarantee the absolute accuracy or completeness of the data. It is always recommended to consult with a qualified healthcare professional or doctor for personalized medical advice and information. We do not assume any responsibility for any consequences arising from the use of the information on this blog.

Thank You

Leave a Reply

Your email address will not be published. Required fields are marked *